BACKGROUND AND OBJECTIVES: As a result of improved clinical and quality-of-life outcomes compared with conventional hemodialysis, interest in nocturnal home hemodialysis (NHD) has steadily increased in the past decade; however, little is known about the flow of patients through NHD programs or about patient-specific predictors of mortality or technique failure associated with this modality. This study addressed this gap in knowledge. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study included 247 NHD patients of the Canadian Slow Long nightly ExtEnded dialysis Programs (CAN-SLEEP) cohort from 1994 through 2006 inclusive. The association between program- and patient-specific variables and risk for adverse outcomes was determined using uni- and multivariable Cox regression. RESULTS: A total of 14.6% of the cohort experienced death or technique failure. Unadjusted 1- and 5-year adverse event-free survival was 95.2 and 80.1%, respectively. Significant predictors of a composite of mortality and technique failure included advanced age (P < 0.001), diabetes (P < 0.001), central venous catheter use (P = 0.01), and inability to perform NHD independently (P = 0.009) and were adjusted for center effect. Weekly frequency of NHD was not predictive. Age and diabetes remained significant with multivariable analysis (hazard ratio 1.07 and 2.64, respectively). Unadjusted 1- and 5-year technique survival was 97.9 and 95.2%, respectively. Only age was a significant predictor of technique failure. CONCLUSIONS: NHD is associated with excellent adverse event-free survival. This study underscores the importance of modality-specific predictors in the success of home hemodialysis, as well as favorable baseline characteristics such as younger age and the absence of diabetes.
BACKGROUND AND OBJECTIVES: As a result of improved clinical and quality-of-life outcomes compared with conventional hemodialysis, interest in nocturnal home hemodialysis (NHD) has steadily increased in the past decade; however, little is known about the flow of patients through NHD programs or about patient-specific predictors of mortality or technique failure associated with this modality. This study addressed this gap in knowledge. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study included 247 NHDpatients of the Canadian Slow Long nightly ExtEnded dialysis Programs (CAN-SLEEP) cohort from 1994 through 2006 inclusive. The association between program- and patient-specific variables and risk for adverse outcomes was determined using uni- and multivariable Cox regression. RESULTS: A total of 14.6% of the cohort experienced death or technique failure. Unadjusted 1- and 5-year adverse event-free survival was 95.2 and 80.1%, respectively. Significant predictors of a composite of mortality and technique failure included advanced age (P < 0.001), diabetes (P < 0.001), central venous catheter use (P = 0.01), and inability to perform NHD independently (P = 0.009) and were adjusted for center effect. Weekly frequency of NHD was not predictive. Age and diabetes remained significant with multivariable analysis (hazard ratio 1.07 and 2.64, respectively). Unadjusted 1- and 5-year technique survival was 97.9 and 95.2%, respectively. Only age was a significant predictor of technique failure. CONCLUSIONS:NHD is associated with excellent adverse event-free survival. This study underscores the importance of modality-specific predictors in the success of home hemodialysis, as well as favorable baseline characteristics such as younger age and the absence of diabetes.
Authors: Christopher T Chan; John S Floras; Judith A Miller; Robert M A Richardson; Andreas Pierratos Journal: Kidney Int Date: 2002-06 Impact factor: 10.612
Authors: Robert P Pauly; Michael Copland; Paul Komenda; Adeera Levin; Andreas Pierratos; Christopher T Chan Journal: Clin J Am Soc Nephrol Date: 2008-10-01 Impact factor: 8.237
Authors: A Pierratos; M Ouwendyk; R Francoeur; S Vas; D S Raj; A M Ecclestone; V Langos; R Uldall Journal: J Am Soc Nephrol Date: 1998-05 Impact factor: 10.121
Authors: Bruce F Culleton; Michael Walsh; Scott W Klarenbach; Garth Mortis; Narine Scott-Douglas; Robert R Quinn; Marcello Tonelli; Sarah Donnelly; Matthias G Friedrich; Andreas Kumar; Houman Mahallati; Brenda R Hemmelgarn; Braden J Manns Journal: JAMA Date: 2007-09-19 Impact factor: 56.272
Authors: Kirsten L Johansen; Rebecca Zhang; Yijian Huang; Shu-Cheng Chen; Christopher R Blagg; Alexander S Goldfarb-Rumyantzev; Chistopher D Hoy; Robert S Lockridge; Brent W Miller; Paul W Eggers; Nancy G Kutner Journal: Kidney Int Date: 2009-08-19 Impact factor: 10.612
Authors: Braden J Manns; Michael W Walsh; Bruce F Culleton; Brenda Hemmelgarn; Marcello Tonelli; Melissa Schorr; Scott Klarenbach Journal: Kidney Int Date: 2008-12-24 Impact factor: 10.612
Authors: Robert P Pauly; John S Gill; Caren L Rose; Reem A Asad; Anne Chery; Andreas Pierratos; Christopher T Chan Journal: Nephrol Dial Transplant Date: 2009-07-07 Impact factor: 5.992
Authors: Eduardo Lacson; Jianglin Xu; Rita S Suri; Gihad Nesrallah; Robert Lindsay; Amit X Garg; Keith Lester; Norma Ofsthun; Michael Lazarus; Raymond M Hakim Journal: J Am Soc Nephrol Date: 2012-02-23 Impact factor: 10.121
Authors: Nikhil Shah; Frances Reintjes; Mark Courtney; Scott W Klarenbach; Feng Ye; Kara Schick-Makaroff; Kailash Jindal; Robert P Pauly Journal: Clin J Am Soc Nephrol Date: 2017-07-24 Impact factor: 8.237
Authors: Shih-Han S Huang; Jennifer MacRae; Dana Ross; Rameez Imtiaz; Brittany Hollingsworth; Gihad E Nesrallah; Michael A Copland; Philip A McFarlane; Christopher T Chan; Deborah Zimmerman Journal: Clin J Am Soc Nephrol Date: 2019-01-18 Impact factor: 8.237
Authors: Bessie A Young; Christopher Chan; Christopher Blagg; Robert Lockridge; Thomas Golper; Fred Finkelstein; Rachel Shaffer; Rajnish Mehrotra Journal: Clin J Am Soc Nephrol Date: 2012-10-04 Impact factor: 8.237
Authors: Scott Klarenbach; Marcello Tonelli; Robert Pauly; Michael Walsh; Bruce Culleton; Helen So; Brenda Hemmelgarn; Braden Manns Journal: J Am Soc Nephrol Date: 2013-11-14 Impact factor: 10.121